Symons Julian A. 4
4 · Aligos Therapeutics, Inc. · Filed Dec 3, 2020
Insider Transaction Report
Form 4
Symons Julian A.
See Remarks
Transactions
- Award
Stock Option (Right to Buy)
2020-12-01+200,000→ 200,000 totalExercise: $16.18Exp: 2030-12-01→ Common Stock (200,000 underlying)
Footnotes (1)
- [F1]1/48th of the total number of shares vest in forty-eight (48) successive and equal monthly installments measured from December 1, 2020 (the "Vesting Commencement Date"), such that 100% of the shares subject to the option will be fully vested and exercisable on the fourth anniversary of the Vesting Commencement Date.